1177 Share Price

Open 5.52 Change Price %
High 5.65 1 Day 0.14 2.55
Low 5.52 1 Week 0.32 6.02
Close 5.64 1 Month -0.02 -0.35
Volume 30116369 1 Year -2.07 -26.85
52 Week High 7.64
52 Week Low 4.61
1177 Important Levels
Resistance 2 5.76
Resistance 1 5.71
Pivot 5.60
Support 1 5.57
Support 2 5.52
HKG HongKong Most Active Stocks
0261 0.01 0.00%
0566 3.91 0.00%
0136 0.59 -4.84%
0459 0.05 25.00%
8171 0.02 0.00%
0061 0.02 0.00%
0395 0.16 -5.88%
0981 1.03 0.00%
0997 0.04 0.00%
2324 0.06 0.00%
More..
HKG HongKong Top Gainers Stocks
0459 0.05 25.00%
8048 0.14 16.67%
1386 1.63 15.60%
0007 0.78 14.71%
0685 1.29 14.16%
0149 1.19 13.33%
0602 0.52 13.04%
8148 0.18 12.50%
0500 1.17 12.50%
0660 0.09 12.50%
More..
HKG HongKong Top Losers Stocks
8165 0.08 -27.27%
0274 0.03 -25.00%
4333 60.00 -25.00%
8002 4.00 -15.97%
2369 0.70 -12.50%
1094 0.07 -12.50%
8190 0.14 -12.50%
1192 0.08 -11.11%
1191 0.25 -10.71%
8051 0.67 -10.67%
More..

Sino Biopharmaceutical Ltd. (HKG: 1177)

1177 Technical Analysis 3
As on 7th Dec 2016 1177 Share Price closed @ 5.64 and we RECOMMEND Buy for LONG-TERM with Stoploss of 5.47 & Buy for SHORT-TERM with Stoploss of 5.46 we also expect STOCK to react on Following IMPORTANT LEVELS.
1177 Target for December
1st Target up-side 5.63
2nd Target up-side 5.84
3rd Target up-side 6.05
1st Target down-side 5.01
2nd Target down-side 4.8
3rd Target down-side 4.59
1177 Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.sinobiopharm.com
1177 Address
1177
Office Tower
Unit 09, 41st Floor
Wanchai,
Hong Kong
Phone: 852 2802 9886
Fax: 852 2880 0847
1177 Latest News
Interactive Technical Analysis Chart Sino Biopharmaceutical Ltd. ( 1177 HKG HongKong )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Sino Biopharmaceutical Ltd.
1177 Business Profile
Sino Biopharmaceutical Limited, an investment holding company, researches, develops, manufactures, and markets Chinese medicines and chemical medicines primarily in Mainland China. The company operates in three segments; Modernized Chinese Medicines and Chemical Medicines, Investment, and Others. Its principal products include cardio-cerebral medicines, such as Yilunping and Tuotuo tablets, as well as Tianqingning injections; hepatitis medicines comprising Tianqingganmei injections, Runzhong dispersible tablets, Mingzheng capsules, Tianqingganping enteric capsules, Ganlixin injections and capsules, and Tianqingfuxin injections and capsules; oncology medicines consisting of Tianqingyitai, Renyi, and Zhiruo injections; parenteral nutritious medicines, such as Xinhaineng and Fenghaineng fructose injections; anti-infectious medicines, including Tiance injections; and anorectal medicines comprising Getai tablets. The company also develops medicines for treating tumors, pain, diabetes, respiratory system diseases, and other diseases, as well as offers parenteral nutritious, orthopedic, and analgesic medicines. In addition, it provides research and development services; and operates Chia Tai Shaoyang Orthopedic Hospital located in Hunan Province of the People’s Republic of China, as well as is engaged in the retail of pharmaceutical products. The company was incorporated in 2000 and is headquartered in Wanchai, Hong Kong.